Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mathew, J.
Right arrow Articles by Franklin, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mathew, J.
Right arrow Articles by Franklin, C.
(Chest. 1995;108:73-77.)
© 1995 American College of Chest Physicians

Results of Surgical Treatment for Infective Endocarditis in Intravenous Drug Users

James Mathew MD1; Gerard Abreo MD2; Krishna Namburi MD2; Leela Narra MD2; and Cory Franklin MD2

1 From the Divisions of Adult Cardiology and Critical Care Medicine, Department of Medicine, Cook County Hospital, Chicago; and the Department of Medicine, the University of Illinois at Chicago
2 From the Divisions of Adult Cardiology and Critical Care Medicine, Department of Medicine, Cook County Hospital, Chicago

Objective: To determine the early and late results of surgical treatment for infective endocarditis (IE) in intravenous drug users (IVDU).

Design: Cohort study of consecutive IVDUs undergoing surgical treatment for IE.

Setting: Large public hospital serving the urban population of Chicago, Ill.

Patients: Consecutive IVDUs operated on between July 1982 and June 1991 for IE.

Main outcome measures: Death, stroke, noncerebral systemic embolization, major bleeding, recurrent endocarditis, and repeated valve replacement.

Results: There were 80 patients, 58 men and 22 women, with a mean age of 37.5±10 (SD) years. The hospital course in all patients and follow-up data on 75 (94%) patients were complete. The primary indication for surgery was acute congestive heart failure in 44 (56%), persistent sepsis in 21 (26%), and multiple systemic embolization in 15 (19%) patients. Six patients (7.5%) died within 30 days of surgery. An additional 13 of 69 patients (17.6%) died during the follow-up, 8 from cardiovascular causes. The probability of survival at 36 months and at 60 months was 0.74±0.05 (SE) and 0.70±0.05, respectively. Seventeen (30%) of the survivors had at least one major cardiovascular event; 6 (8.8%) had recurrent endocarditis, 4 (5.8%) had stroke, 3 (4.4%) had extracerebral bleeding, 1 had extracerebral systemic embolism, and 3 (4.4%) required repeated valve replacement. Probability of event-free survival at 36 months and 60 months was 0.65±0.06 and 0.52±0.08, respectively. The median duration of event-free survival was 65 months.

Conclusion: Since the expected mortality without surgery in patients with IE in whom medical treatment fails is almost 100%, it is concluded that surgical treatment is indicated for, and substantially improves the outlook for early and late survival of, IVDUs with IE who fail to respond to medical management.

Key Words: endocarditis • endocarditis-treatment • infective endocarditis-surgery • substance abuse-intravenous-complications

Submitted on September 12, 1994
Accepted on December 16, 2007




This article has been cited by other articles:


Home page
ICVTSHome page
A. Wahba and D. Nordhaug
What are the long-term results of cardiac valve replacements in left sided endocarditis with a history of i.v. drug abuse?
Interactive CardioVascular and Thoracic Surgery, October 1, 2006; 5(5): 608 - 610.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American College of Chest Physicians.